Pediatric Mitral Valve Insufficiency Clinical Presentation

  • Author: Monesha Gupta, MD, MBBS, FAAP, FACC, FASE; Chief Editor: Stuart Berger, MD   more...
 
Updated: Feb 1, 2010
 

History

The nature and severity of symptoms in patients with mitral regurgitation (MR) relates to etiology, rate of onset and progression, left ventricle (LV) function, pulmonary artery pressure, and the presence of preexisting valvular or myocardial diseases.

Children with minor degrees of mitral regurgitation are usually asymptomatic. With increased amounts of mitral regurgitation, fatigue may be reported, but children can tolerate more severe mitral regurgitation surprisingly better than adults can.

Once pulmonary hypertension develops, complaints such as tachypnea and dyspnea with light activity become more prominent.

With the most severe mitral regurgitation, children may experience limited growth and failure to thrive. Hemoptysis can develop during the later stages.

Children may remain asymptomatic with no complications of mitral regurgitation until the second or third decade of life.

An indolent course of mitral regurgitation may be deceptive because of the ability of the heart to compensate for the altered hemodynamics. This occurs because of changes in cardiac pump loading such that increased diastolic filling increases preload, whereas LV ejection, in part into the left atrium, reduces afterload.

By the time symptoms become apparent, serious and irreversible LV dysfunction may have developed.

Next

Physical

Vital signs

Vital signs are usually normal in mild regurgitation. With increasing mitral regurgitation, heart and respiratory rates may be increased.

In patients with severe mitral regurgitation, arterial pulse has been characterized as having a small volume with a sharp upstroke.

Rarely, irregular pulse may be indicative of associated atrial fibrillation

Cardiac examination

Apical impulse: A left atrial lift is a second impulse resulting from the increased volume that is displaced into the left atrium during systole. The second impulse should be felt near the time of the second heart sound. This sign is most helpful in thin children and young adults because their chest diameters are smaller and their hearts are closer to the chest wall. The cardiac impulse may be displaced to the left, and, in more advanced disease, a double impulse is felt.

Heart sounds: Upon auscultation, the first heart sound is usually slightly diminished, whereas the second heart sound is usually split. With more severe mitral regurgitation, a third heart sound and a mid diastolic low frequency murmur may be present, caused by increased ventricular filling. When pulmonary hypertension develops, the pulmonary component of the second heart sound becomes louder and occurs earlier (as long as right ventricular function is not significantly impaired), reducing the splitting interval.

Ejection systolic click may be present due to mitral valve prolapse.

Murmur: Patients with mild mitral regurgitation may reveal no signs other than a characteristic apical systolic murmur. The sound of the typical mitral regurgitation murmur is characterized as blowing and high pitched, and it is loudest over the apex with radiation to the left axilla. The murmur is often pansystolic, beginning immediately after the first heart sound, and may continue beyond the aortic component of the second heart sound, thus obscuring the murmur. This murmur increases with increased afterload (squatting) and decreases with decreased preload (standing). Occasionally, radiation toward the sternum occurs when posterior leaflet abnormalities are present. Little correlation is noted between intensity of the murmur and severity of mitral regurgitation. The murmur occasionally may be confined to late systole only. The degree of mitral regurgitation in these patients is usually mild.

Other physical findings

Congestive heart failure with pulmonary edema can occur with significant mitral regurgitation and pulmonary findings may be consistent with it. Compression of left main bronchus due to left atrial enlargement can cause ipsilateral wheezing and lung collapse. Significant and sustained mitral regurgitation can be associated with endocarditis and thromboembolism and have associated findings.

Previous
Next

Causes

Although the pathophysiology resulting from mitral regurgitation is similar throughout all age groups, the specific cause of mitral regurgitation differs with age.

Previous
Next

Classification I

The first classification is based on etiology (congenital vs acquired)

Congenital

Congenital cardiac malformation: Most mitral regurgitation in the pediatric population is congenital in origin secondary to a deformed or dysplastic valve.

  • Isolated mitral valve defects - Mitral valve clefts, fenestrations or perforations, double orifice mitral valve, arcade mitral valve, hammock mitral valve, abnormal chordal tissue or insertion, absent or hypoplastic leaflets, accessory leaflets
  • Associated with other congenital heart defects - Endocardial cushion defects (atrioventricular canal defect), transposition of the great arteries, anomalous origin of the left coronary artery

Degenerative disease: Myxomatous degeneration of the mitral valve is usually progressive.

Acquired: In older adolescent and adult patients, mitral regurgitation is likely to be acquired. In these patients, mitral regurgitation can result from numerous problems, including the following:

  • Infection - Endocarditis and myocarditis
  • Inflammation -Rheumatic heart disease, Kawasaki disease, Sweet syndrome and systemic lupus erythematosus (SLE)
  • Structural disorders - Ischemic heart disease and trauma
  • Ischemic (anomalous origin of the left coronary artery, perinatal asphyxia, myocardial infarction)
Previous
Next

Classification II

This classification is based on anatomy.

Mitral annulus disorders

  • Infective endocarditis (abscess formation)
  • Trauma (valvular heart surgery)
  • Paravalvular leak resulting from suture interruption (surgical technical problems, infective endocarditis)
  • Cardiomyopathy (annular dilatation)

Mitral leaflet disorders

  • Infective endocarditis (perforation or interference with valve closure by vegetation)
  • Trauma (tear during percutaneous mitral balloon valvotomy or penetrating chest injury)
  • Tumors (atrial myxoma)
  • Myxomatous degeneration
  • Systemic lupus erythematosus (SLE) - Libman-Sacks lesion
  • Acute rheumatic fever

Disorder of chordae tendineae

Papillary muscle disorders

  • Coronary artery disease (causing dysfunction and, rarely, rupture)
  • Acute global LV dysfunction
  • Infiltrative diseases (amyloidosis, sarcoidosis)
  • Trauma
  • Tumors
Previous
Next

Classification III

This classification is based on whether the disease is acute or chronic.

Acute causes of mitral regurgitation are as follows:

  • Traumatic (eg, percutaneous balloon valvuloplasty, blunt chest trauma)
  • Ischemic (eg, perinatal asphyxia, anomalous origin of left coronary artery from pulmonary artery, myocardial infarction)
  • Neonatal (eg, perinatal asphyxia)
  • Infective (eg, infective endocarditis, myocarditis)

Chronic causes of mitral regurgitation are as follows:

  • Congenital disorders - Mitral valve clefts or fenestrations, parachute mitral valve abnormality, part of any associated congenital heart disease (endocardial cushion defects, transposition of the great arteries, anomalous origin of the left coronary artery)[3]
  • Inflammatory disorders - Rheumatic heart disease, Kawasaki disease, SLE, scleroderma
  • Degenerative disorders - Myxomatous degeneration of mitral valve leaflets (Barlow click-murmur syndrome, prolapsing leaflet, mitral valve prolapse), Marfan syndrome, Ehlers-Danlos syndrome, pseudoxanthoma elasticum, calcification of mitral valve annulus
  • Infective disorders - Infective endocarditis, myocarditis
  • Cardiomyopathy - Dilated cardiomyopathy (dilation of mitral valve annulus and LV cavity [congestive cardiomyopathies, aneurysmal dilation of the LV]),[4] hypertrophic cardiomyopathy, restrictive cardiomyopathy, noncompaction cardiomyopathy
Previous
Next

Classification IV

This classification is based on mitral valve dysfunction as elucidated by Carpentier and colleagues.[5]

  • Type I - Normal leaflet and chordal motion (eg, fenestrations, clefts, perforations in the leaflets)
  • Type II - Leaflet prolapse with excessive chordal motion above annulus (eg, mitral valve prolapse)
  • Type III - Restrictive leaflet or chordal motion (eg, parachute mitral valve)
Previous
 
 
Contributor Information and Disclosures
Author

Monesha Gupta, MD, MBBS, FAAP, FACC, FASE  Associate Professor of Pediatrics, Division of Pediatric Cardiology and Nephrology, Children's Memorial Hermann Hospital, University of Texas Medical School

Monesha Gupta, MD, MBBS, FAAP, FACC, FASE is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Society of Echocardiography, Medical Council of India, Society for Pediatric Research, and Society of Pediatric Echocardiography

Disclosure: Nothing to disclose.

Specialty Editor Board

Ira H Gessner, MD  Professor Emeritus, Pediatric Cardiology, University of Florida College of Medicine

Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Julian M Stewart, MD, PhD  Associate Chairman of Pediatrics, Director, Center for Hypotension, Westchester Medical Center; Professor of Pediatrics and Physiology, New York Medical College

Julian M Stewart, MD, PhD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Gilbert Z Herzberg, MD  Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College; Consulting Staff, Department of Pediatrics, Sound Shore Medical Center

Gilbert Z Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD  Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

References
  1. Ahmed MI, McGiffin DC, O'Rourke RA, Dell'Italia LJ. Mitral regurgitation. Curr Probl Cardiol. Mar 2009;34(3):93-136. [Medline].

  2. Rahimtoola SH. The mitral valve is a complex structure. Foreword. Curr Probl Cardiol. Mar 2009;34(3):89. [Medline].

  3. Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. Apr 2009;157(4):762.e3-10. [Medline].

  4. Pederzolli N, Agostini F, Fiorani V, et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med (Hagerstown). Mar 2009;10(3):259-60. [Medline].

  5. Carpentier A. Congenital malformations of the mitral valve. In: Stark J, de Laval M, eds. Surgery for Congenital Heart Defects. WB Saunders Co; 1983:467-82.

  6. Little SH, Pirat B, Kumar R, et al. Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. JACC Cardiovasc Imaging. Nov 2008;1(6):695-704. [Medline].

  7. Calafiore AM, Gallina S, Iaco AL, et al. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis. Ann Thorac Surg. Mar 2009;87(3):698-703. [Medline].

  8. Wan CK, Suri RM, Li Z, et al. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary?. J Thorac Cardiovasc Surg. Mar 2009;137(3):635-640.e1. [Medline].

  9. Bernal JM, Gutierrez F, Farinas MC, et al. Use of mitral homograft to support a mechanical valve prosthesis: a feasible solution for recurrent mitral valve dysfunction. J Thorac Cardiovasc Surg. Mar 2009;137(3):762-3. [Medline].

  10. Anderson RH, Wilcox BR. The anatomy of the mitral valve. In: Wells FC, Shapiro LM, eds. Mitral Valve Disease. 2nd ed. Butterworth-Heinemann; 1996:4-13.

  11. Barlow JB. Mitral regurgitation. In: Perspectives on the Mitral Valve. FA Davis Co; 1987:113-31.

  12. Carabello BA. Mitral valve regurgitation. Curr Probl Cardiol. Apr 1998;23(4):202-41. [Medline].

  13. Dunn JM. Porcine valve durability in children. Ann Thorac Surg. Oct 1981;32(4):357-68. [Medline].

  14. Eckberg DL, Gault JH, Bouchard RL, et al. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation. Jun 1973;47(6):1252-9. [Medline].

  15. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. Mar 3 2005;352(9):875-83. [Medline].

  16. Kolibash AJ Jr, Kilman JW, Bush CA, et al. Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. Am J Cardiol. Oct 1 1986;58(9):762-7. [Medline].

  17. Kon MW, Myerson SG, Moat NE, Pennell DJ. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis. Jul 2004;13(4):600-7. [Medline].

  18. Krivokapich J. Echocardiography in valvular heart disease. Curr Opin Cardiol. Mar 1994;9(2):158-63. [Medline].

  19. Magovern JH, Moore GW, Hutchins GM. Development of the atrioventricular valve region in the human embryo. Anat Rec. Jun 1986;215(2):167-81. [Medline].

  20. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. Aug 1972;46(2):227-39. [Medline].

  21. Shimoyama H, Sabbah HN, Rosman H, et al. Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. J Am Coll Cardiol. Mar 1 1995;25(3):768-72. [Medline].

  22. Skoularigis J, Sinovich V, Joubert G, Sareli P. Evaluation of the long-term results of mitral valve repair in 254 young patients with rheumatic mitral regurgitation. Circulation. Nov 1994;90(5 Pt 2):II167-74. [Medline].

  23. Tribouilloy C, Shen WF, Leborgne L, et al. Comparative value of Doppler echocardiography and cardiac catheterization for management decision-making in patients with left-sided valvular regurgitation. Eur Heart J. Feb 1996;17(2):272-80. [Medline].

Previous
Next
 
Acute stage of mitral regurgitation (MR).
Chronic compensated stage of mitral regurgitation (MR).
Chronic decompensated stage of mitral regurgitation (MR).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.